107 related articles for article (PubMed ID: 16109562)
1. [Clinical analysis of serum endothelin in type 2 diabetic patients with vascular complications].
Fang YH; Zhang JP; Zhou SX; Zheng JF; Yu YW; Yan SG; Fan WK; Chen YS
Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):1007-8, 1011. PubMed ID: 16109562
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between serum vWF and PAF in type 2 diabetic patients and diabetic nephropathy].
Fang YH; Zhang JP; Zhou SX; Zheng JF; Yu YW; Yan SG; Fan WK; Cheng YS
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):729-31. PubMed ID: 15958323
[TBL] [Abstract][Full Text] [Related]
3. The relationship between adrenomedullin, metabolic factors, and vascular function in individuals with type 2 diabetes.
Lim SC; Morgenthaler NG; Subramaniam T; Wu YS; Goh SK; Sum CF
Diabetes Care; 2007 Jun; 30(6):1513-9. PubMed ID: 17384335
[TBL] [Abstract][Full Text] [Related]
4. [Significance of increased endothelin level for development of sequelae of diabetes mellitus].
Haak T; Jungmann E; Hillmann U; Felber A; Usadel KH
Med Klin (Munich); 1993 May; 88(5):291-6. PubMed ID: 8326915
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil surface expression of CD11b and CD62L in diabetic microangiopathy.
Mastej K; Adamiec R
Acta Diabetol; 2008 Sep; 45(3):183-90. PubMed ID: 18496641
[TBL] [Abstract][Full Text] [Related]
6. Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls.
Neri S; Signorelli SS; Torrisi B; Pulvirenti D; Mauceri B; Abate G; Ignaccolo L; Bordonaro F; Cilio D; Calvagno S; Leotta C
Clin Ther; 2005 Nov; 27(11):1764-73. PubMed ID: 16368447
[TBL] [Abstract][Full Text] [Related]
7. Plasma endothelin levels in NIDDM patients with macroangiopathy.
Donatelli M; Colletti I; Bucalo ML; Russo V; Verga S
Diabetes Res; 1994; 25(4):159-64. PubMed ID: 7648786
[TBL] [Abstract][Full Text] [Related]
8. Vascular damage and not hypertension per se influences endothelin-1 plasma levels in patients with non insulin dependent diabetes mellitus.
Perfetto F; Tarquini R; de Leonardis V; Piluso A; Becucci A; Anselmi B; Curradi C; Tapparini L; Tarquini B
Recenti Prog Med; 1997; 88(7-8):317-20. PubMed ID: 9270291
[TBL] [Abstract][Full Text] [Related]
9. [Changes of plasma endothelin-1 and vascular endothelial growth factor in diabetic retinopathy and the clinical application value thereof].
Zhu H; Shi CH
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2837-9. PubMed ID: 18167288
[TBL] [Abstract][Full Text] [Related]
10. Cortisol secretion in patients with type 2 diabetes: relationship with chronic complications.
Chiodini I; Adda G; Scillitani A; Coletti F; Morelli V; Di Lembo S; Epaminonda P; Masserini B; Beck-Peccoz P; Orsi E; Ambrosi B; Arosio M
Diabetes Care; 2007 Jan; 30(1):83-8. PubMed ID: 17192338
[TBL] [Abstract][Full Text] [Related]
11. [Determination of N-acetyl-glucosaminidase (NAG) in diabetic subjects].
Melosi A; Ricci F
Quad Sclavo Diagn; 1983 Mar; 19(1):113-20. PubMed ID: 6675040
[TBL] [Abstract][Full Text] [Related]
12. [The relationship between the plasma levels of endothelin and angiopathy in diabetic patients].
Zeng ZP; Tang D; Sun ML
Zhonghua Nei Ke Za Zhi; 1994 Jul; 33(7):467-9. PubMed ID: 7867443
[TBL] [Abstract][Full Text] [Related]
13. Plasma homocysteine, oxidative stress and endothelial function in patients with Type 1 diabetes mellitus and microalbuminuria.
Wotherspoon F; Laight DW; Browne DL; Turner C; Meeking DR; Allard SE; Munday LJ; Shaw KM; Cummings MH
Diabet Med; 2006 Dec; 23(12):1350-6. PubMed ID: 17116187
[TBL] [Abstract][Full Text] [Related]
14. [If the level of cystatin C in children and adolescents with type 1 diabetes an early marker for diabetic nephropathy?].
Peczyńska J; Urban M; Głowińska B; Florys B
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):141-6. PubMed ID: 16232367
[TBL] [Abstract][Full Text] [Related]
15. Diastolic dysfunction and abnormalities of the microcirculation in type 2 diabetes.
Brooks BA; Franjic B; Ban CR; Swaraj K; Yue DK; Celermajer DS; Twigg SM
Diabetes Obes Metab; 2008 Sep; 10(9):739-46. PubMed ID: 17941867
[TBL] [Abstract][Full Text] [Related]
16. [Our preliminary observations of plasma endothelin behavior in type II diabetes mellitus].
Bruno CM; Neri S; D'Amico R; Raciti C; Urso G
Minerva Med; 1996; 87(7-8):331-3. PubMed ID: 8975171
[TBL] [Abstract][Full Text] [Related]
17. Endothelial dysfunction and oxidative stress in type 1 and type 2 diabetic patients without clinical macrovascular complications.
De Mattia G; Bravi MC; Laurenti O; Moretti A; Cipriani R; Gatti A; Mandosi E; Morano S
Diabetes Res Clin Pract; 2008 Feb; 79(2):337-42. PubMed ID: 17949845
[TBL] [Abstract][Full Text] [Related]
18. Assessment of oxidative stress and endothelial dysfunction in Asian Indians with type 2 diabetes mellitus with and without macroangiopathy.
Singhania N; Puri D; Madhu SV; Sharma SB
QJM; 2008 Jun; 101(6):449-55. PubMed ID: 18385148
[TBL] [Abstract][Full Text] [Related]
19. [Levels of soluble adhesion molecules among normal and hypertensive type 2 diabetic patients].
Rubio-Guerra AF; Vargas-Robles H; Medina-Santillán R; Escalante-Acosta BA
Gac Med Mex; 2008; 144(1):11-4. PubMed ID: 18619052
[TBL] [Abstract][Full Text] [Related]
20. Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial.
Azadbakht L; Atabak S; Esmaillzadeh A
Diabetes Care; 2008 Apr; 31(4):648-54. PubMed ID: 18184902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
